Weave Communications, Inc. (WEAV) · Sep 21, 2026 · Acquisition
HSR cleared — HSR waiting period terminated; stockholder approval remains
Weave’s take-private transaction clears HSR review, but the deal remains subject to stockholder approval and other closing conditions.
Weave is a vertical software platform for small and midsized healthcare practices, combining patient communications, workflow tools, and payments while expanding into AI-powered products. The company agreed on August 18, 2026 to be acquired by Francisco Partners for $7.40 per share in cash, so this filing advances an already-public take-private process rather than changing the underlying business strategy.
One regulatory condition is now cleared. Early termination of the U.S. antitrust waiting period removes a required closing hurdle. 〔0〕
The milestone is procedural, not a better deal. The filing says HSR clearance satisfies only one closing condition; Weave still needs stockholder approval and other customary conditions. 〔1〕 Because the acquisition itself was announced on August 18, the direction was already known; the new information is that the transaction has passed one expected regulatory checkpoint.
The timetable remains broadly intact. Management continues to target closing in the fourth quarter of 2026, but does not provide a definitive closing date. 〔2〕
Bottom line: This is clean progress for the announced acquisition, but not a change to its economics or strategic rationale. It reduces execution risk modestly while leaving the shareholder vote as the next meaningful gate. citeturn0search0turn0search5
Stockholder vote and Q4 2026 closing
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!